The human immunodeficiency virus (HIV-1) particularly attacks CD4 lymphocytes, a type of white blood cell considered to be the conductor of the immune system. Hamza Loucif, a doctoral student in virology and immunology, and ...
Oct 14, 2021
0
2
For nearly a decade, scientists have known that HIV integrates itself into genes in cells that have the potential to cause cancer. And when this happens in animals with other retroviruses, those animals often develop cancer. ...
Oct 13, 2021
0
50
(HealthDay)—About one in four Hispanic persons tested for HIV are aware of preexposure prophylaxis (PrEP) and about one in five of those eligible for referral are referred to PrEP providers, according to research published ...
Oct 8, 2021
0
2
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression ...
Oct 7, 2021
0
9
A new combination treatment for HIV can strengthen a patient's immune response against the virus even after they stop taking traditional medications, according to a study published in the journal Science Immunology we co-led ...
Sep 30, 2021
0
1
In a Bucharest back street, drug addicts rush towards an ambulance handing out free syringes. While the eyes of the world focus on the COVID-19 pandemic, the fight against HIV has slowed down in Eastern Europe.
Sep 29, 2021
0
6
England is on track to have diagnosed 95% of people living with HIV by 2025, putting it in a strong position to eliminate HIV transmission by 2030, say researchers at the MRC Biostatistics Unit, University of Cambridge, and ...
Sep 23, 2021
0
12
Researchers at City of Hope, a world-renowned research and treatment organization for cancer and diabetes, and Menzies Health Institute Queensland at Griffith University have developed a novel anti-HIV protein that suppressed ...
Sep 20, 2021
0
56
The Wits Vaccines and Infectious Diseases Analytical (VIDA) research unit conducted the phase 1B/2A clinical trial. The findings, published in The Lancet HIV on 17 August 2021, show that the AstraZeneca COVID-19 vaccine is ...
Sep 13, 2021
0
7
HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it. The vast majority of people living with HIV require daily medication to suppress the virus ...
Sep 9, 2021
0
37
